Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2026-02-28 @ 11:26 PM
Study NCT ID:
NCT02100618
Status:
WITHDRAWN
Last Update Posted:
2015-07-20
First Post:
2014-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01
Start Date Type:
None
Primary Completion Date:
2015-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2015-04
Completion Date Type:
ESTIMATED
First Submit Date:
2014-03-27
First Submit QC Date:
None
Study First Post Date:
2014-04-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-07-16
Last Update Post Date:
2015-07-20
Last Update Post Date Type:
ESTIMATED